💸 The Tape

Tilray Brands announced the next phase of its U.S. beverage overhaul on Thursday, and the headline number is $20 million in annualized cost savings by the end of fiscal 2028. The more important number is buried in the boilerplate: a global beverage platform doing roughly $500 million in pro forma annual revenue, running on six breweries instead of ten, with a distributor network that’s already 9% leaner than it was in January 2025 and about to get leaner still.

This is a company finishing the job of becoming a beverage operator rather than a cannabis company that happens to own breweries.

What’s been done

Since the start of 2025, Tilray has shuttered four U.S. brewing facilities: Hop Valley in Eugene, the Redhook Brewlab, the Revolver brewery in Texas and, as of the current quarter, Terrapin’s brewing operations in Athens, which have been folded into other Tilray plants while the taproom and repackaging stay put. The Atwater brand was sold outright. SKU count has been cut 28%, with the portfolio narrowed to established regional brands, select national brands, non-alcoholic beverages and functional energy drinks.

Irwin Simon’s framing is characteristically blunt: “We have taken meaningful steps to simplify our U.S. beverage operations.” The goal was never to run ten breweries at partial utilization. It was to acquire the brands, strip out the redundant footprint and run the survivors hot.

What comes next

Phase two is about the middle of the supply chain. Tilray will sell or monetize the brewing and warehouse facilities that consolidation made redundant, which converts stranded assets into cash and removes fixed cost in one move. It will push through procurement, warehousing and logistics changes designed to lower per-case production cost and lift utilization at the six remaining plants. And it will keep cutting distributors. Simon called distributor consolidation “our next priority,” and the release says the network plan will be substantially complete through fiscal 2028.

Then there’s Carlsberg. Starting January 1, 2027, Tilray becomes the exclusive U.S. brewing and commercial partner for Carlsberg, Carlsberg Elephant, 1664 and 1664 Blanc, targeting about one million cases in year one using existing capacity. That’s the consolidation thesis paying off in real time: the same breweries that were underutilized in 2024 now have room to contract-brew a global lager brand without new capex. Every incremental case from Carlsberg drops through at a margin the legacy portfolio never earned.

Fiscal 2027 adjusted EBITDA guidance of $68 to $75 million was reaffirmed, and management says it already reflects the cost program underway. The savings target is therefore upside to fiscal 2028, not a rescue for fiscal 2027.

The gaps

The release is light on specifics where investors would want them. No headcount figure. No capex number. No segment revenue breakdown for the beverage business on a standalone basis. No detail on BrewDog integration beyond a mention in the tags. And the timeline is inconsistent: one section says the distributor work runs through fiscal 2028, while the forward-looking language refers to restructuring “substantially completed by the end of fiscal 2027.” Craft beer as a category is contracting, and Tilray’s own beverage revenue in the first quarter was propped up by the BrewDog acquisition rather than organic growth. A smaller, more efficient platform in a shrinking category is still in a shrinking category.

But the operational logic holds. Six breweries, fewer SKUs, fewer distributors, a global lager partnership and $20 million of cost coming out. That’s a beverage business that can earn its keep without cannabis ever contributing a dollar in the U.S.

The speculative part

Now for what the release doesn’t say, and what it’s worth thinking about.

Tilray is building a national three-tier beverage infrastructure: six TTB-permitted breweries spread across the country, a rationalized distributor network, established retail relationships through regional brands like Montauk, SweetWater and Terrapin, and a growing non-alcoholic portfolio. That is, almost line for line, the architecture that Rep. Beth Van Duyne’s Beverage Regulatory Parity Act would require for hemp-derived THC beverages: TTB permits, a production-to-retail three-tier system modeled on alcohol, a per-milligram federal excise tax, a 21-plus standard, mandatory testing and labeling rules. Rep. Morgan Griffith has floated pairing that framework with his own HEMP Act in a lame-duck reconciliation package ahead of the December 11 deadline that would otherwise gut the hemp beverage market.

If something like that passed, the companies positioned to win wouldn’t be the hemp startups selling seltzers through smoke shops. They’d be the operators who already hold TTB permits, already run distributor contracts in every major market, already have cold-chain logistics, and already know how to sell a 12-ounce can to a grocery buyer. Tilray has all of that. It also has a cannabis division with formulation expertise, a hemp foods business, and a CEO who has spent three years telling anyone who’ll listen that beverage is the bridge to U.S. cannabis.

The breweries Tilray just consolidated into six efficient plants could, in theory, run a THC seltzer line on the same canning equipment. The distributors it’s keeping could carry it. The retail accounts that stock SweetWater could stock the THC version next to it. Nothing in Thursday’s release mentions hemp, THC or cannabis beverages, and the company has given no indication it’s planning any of this.

That’s the point. This is purely speculation, and it should be read that way. But when a company spends two years building the exact distribution chassis that a pending federal bill would require for a new intoxicating beverage category, and that company’s CEO has been openly waiting for a U.S. cannabis entry point, it’s at least worth noticing that the pieces fit. If the Van Duyne framework or something like it becomes law, Tilray wouldn’t need to build anything. It would just need to brew it.

📈 Dog Walkers

$VEXTF ( ▲ 6.82% ) Hits Ohio Dispensary Cap

Vext Science secured its eighth and final Ohio dispensary license this week, a provisional award from the Division of Cannabis Control for a site in Amelia, Clermont County, on the east side of Greater Cincinnati. Ohio allows one operator a maximum of eight retail locations. Vext now holds all eight.

The Amelia site is the third and last license granted to Vext under the DCC’s 10(B) expansion program, following Fairfield, which opened in June, and a second Columbus store at 4410 Roberts Road now under construction. Six dispensaries are open today: Jackson, Columbus, Athens, Jeffersonville, Portsmouth and Fairfield. Columbus No. 2 is expected in Q1 2027 and Amelia by the end of Q3 2027, subject to permitting. Supply comes from the company’s Jackson Tier 1 cultivation facility, 25,000 square feet with room to double, plus a fully operational manufacturing plant.

CEO Eric Offenberger’s framing is about operating leverage rather than growth for its own sake. “Amelia completes that footprint,” he said, adding that the full eight-store build is “when we expect the model to really pay off,” with “more of every sales dollar turning into cash.” Vext cites its FY2025 filings for having among the highest free cash flow margins in U.S. cannabis retail, and the pitch is that a capped retail network fed by owned cultivation is how a small operator earns those margins.

The gaps are the ones you’d expect from a micro-cap. No capex figure for the two remaining builds, no revenue disclosure in the release, and a two-year runway to full footprint during which Ohio’s wholesale pricing continues to compress as more cultivation comes online. The Amelia site itself is a commercial corridor with residential development planned, which is a bet on where Cincinnati grows, not where it is.

Still, in a limited-license state where the big MSOs have been at the cap for a year, a Canadian-listed operator quietly hitting eight stores with its own grow is the kind of footprint that gets noticed when someone needs an Ohio asset.

📺 Trade To Black

Earnings Season Gets Better: Verano and Jushi Deliver | TTB Presented by Flowhub

• Verano CEO George Archos and CIO Aaron Miles join the show to unpack a strong Q3: revenue up 5% to $212M, 47% gross margin, $50M adjusted EBITDA, and operating cash flow nearly doubled to $49M as tax expense collapsed. Net loss narrowed to $4M from $44M, cash sits at $102M, and capex guidance was raised to $54–60M.

• Nine-month operating cash flow is $98M versus $39M last year, the clearest picture yet of what Schedule III medical relief does for a Florida-heavy MSO.

• Flowhub’s Kyle Sherman recaps the NuggMD Check In poll: dispensary staff are the most trusted source for product and dosing info at 62.6%, well ahead of doctors at 45.1%, while AI chatbots earn just 6.9% high trust.

• News rundown: Michigan Rep. Jay DeBoyer files a bill to pause the state’s 24% wholesale tax for a year as revenue falls short of the $420M projection, and Rep. Steve Cohen drops a sweeping CSA rewrite that would shift scheduling authority to HHS, end mandatory minimums and remove marijuana from the law entirely.